ecancermedicalscience

Review

The neutrophil-to-lymphocyte ratio: a narrative review

12 Dec 2016
Sara Socorro Faria, Paulo César Fernandes Jr, Marcelo José Barbosa Silva, Vladmir C Lima, Wagner Fontes, Ruffo Freitas-Junior, Agda Karina Eterovic, Patrice Forget

Cellular-mediated inflammatory response, lymphocytes, neutrophils, and monocytes are increasingly being recognised as having an important role in tumorigenesis and carcinogenesis. In this context, studies have suggested that the neutrophil-to-lymphocyte ratio (NLR) can be used as an independent prognostic factor in a variety of cancers. Particularly in breast cancer, several studies have shown that a high NLR is associated with shorter survival. Because the NLR can be easily determined from the full blood count, it could potentially provide a simple and inexpensive test cancer prognosis. This review addresses the possibilities and limitations of using the NLR as a clinical tool for risk stratification helpful for individual treatment of breast cancer patients. The potential underlying phenomena and some perspectives are discussed.

Related Articles

Sudarshan Govender, Tamsin K Phillips, Fiona M Walter, Sarah Day, Bothwell Guzha, Suzanne E Scott, Zvavahera M Chirenje, John E Ataguba, Nomonde Mbatani, Nazia Fakie, Jennifer Moodley
Cassio Murilo Hidalgo Filho, Mateus Marinho Nogueira Soares, Wesley Antonio Lopes de Lima, Laura Testa, Marcela Simonis Martins Ferrari, Renata Colombo Bonadio
Nairica Eurico Rebello, Anita Spadigam, Anita Dhupar, Jochima Cota, Vikas Dhupar
Tooba Ali, Laraib Khan, Bilal Mazhar Qureshi, Asim Hafiz, Maria Tariq, Khurram Minhas, Nasir Ali, Ahmed Nadeem Abbasi
Swasthik Upadhya, Sameer Rastogi, Adarsh Barwad, Shamim Ahmed Shamim, Dikhra Khan, Sudheer Arava, Vineeta Ojha, Akshit Kumar Ganesan Karthikeyan, Akshya Kumar Bisoi